
    
      Study subjects will receiving 50,000 units of Vitamin D3 if they receive Remicade infusions
      every 4-6 weeks. Study subjects will receiving 100,000 units of Vitamin D3 if they receive
      Remicade infusions every 6-8 weeks.
    
  